Govt Considers Ban On Two Antibiotics For Poultry And Animal Feed Supplements

New Delhi: The government is considering banning the production, import and distribution of the chloramphenicol and nitrofurans classes of antibiotics for use in any food-producing animal rearing system, after it has been found that these drugs are misused in poultry and other animal feed supplements.

Both are commonly used antibiotics to treat bacterial and urinary infections in humans.

The Drugs Technical Advisory Board (DTAB) – India’s top drug advisory body – will soon take up the issue of imposing a total ban on the import and production of chloramphenicol and nitrofuran drugs for use in the food- producing systems, people in the know told ET.

The matter was discussed by the Drugs Consultative Committee (DCC) earlier where the members were of the view that drugs were often being misused for poultry and other animal feed supplements. Therefore, the committee agreed with a proposal for banning the import, production, distribution and sales of these drugs.

The Marine Products Export Development Authority (MPEDA) had also submitted a representation to the Department of Animal Husbandry and Dairying last year raising the same issue, after which the matter was considered by the Empowered Committee on Animal Health.

Following this, the Ministry of Fisheries, Animal Husbandry and Dairying issued a memorandum last year in October to the MPEDA, stating that the committee had no objection to a total ban on import, production, distribution and sales of chloramphenicol and nitrofuran drugs for use in any food producing animal rearing systems.

The MPEDA then asked the Ministry of Health & Family Welfare to take the necessary steps to implement the committee’s recommendation.

“The matter will finally be taken up by the DTAB after which a notification to this effect is likely to come,” said a person in the know.

Related Posts

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

NEW DELHI:  In a move to bolster pharmaceutical manufacturing standards across India, the Central Drugs Standard Control Organisation (CDSCO) has instructed state drug regulators to ensure rigorous compliance with the updated…

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

Chennai:  Indian Institute of Technology Madras (IIT Madras) researchers have developed and patented a cost-effective, user-friendly, and minimally invasive glucose monitoring device for diabetes patients. They have reimagined the device…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

Rising Tide of Spurious Drugs in India: Recent Cases Highlight Nationwide Crackdown Amid Quality Concerns

Rising Tide of Spurious Drugs in India: Recent Cases Highlight Nationwide Crackdown Amid Quality Concerns

AGTF arrests man accused of smuggling drugs into USA by concealing them in granite lamps

AGTF arrests man accused of smuggling drugs into USA by concealing them in granite lamps

DCA raids expose steroid trade in Hyd gyms

DCA raids expose steroid trade in Hyd gyms

SPARSH Hospitals is poised to ‘Touch’ with Compassion Lives of Cancer Patients

SPARSH Hospitals is poised to ‘Touch’ with Compassion Lives of Cancer Patients